Strains Mycobacterium tuberculosis
Yüklə 101,21 Kb. Pdf görüntüsü
|
- Bu səhifədəki naviqasiya:
- References
- Virulent Mycobacterium tuberculosis Strains Evade Apoptosis of Infected Alveolar Macrophages 1 Joseph Keane
- ) undergo apoptosis following infection with Mycobacterium tuberculosis in vitro. Apoptosis
- ) induced significantly more AM apoptosis than virulent strains ( M. tuberculosis H37Rv, Erdman, M. tuberculosis
|
of May 3, 2017. This information is current as Macrophages Evade Apoptosis of Infected Alveolar Strains Mycobacterium tuberculosis Virulent Joseph Keane, Heinz G. Remold and Hardy Kornfeld http://www.jimmunol.org/content/164/4/2016 doi: 10.4049/jimmunol.164.4.2016 2000; 164:2016-2020; ;
http://www.jimmunol.org/content/164/4/2016.full#ref-list-1 , 13 of which you can access for free at:
This article Subscription http://jimmunol.org/subscription is online at:
Information about subscribing to Permissions http://www.aai.org/About/Publications/JI/copyright.html Submit copyright permission requests at:
http://jimmunol.org/alerts Receive free email-alerts when new articles cite this article. Sign up at: Print ISSN: 0022-1767 Online ISSN: 1550-6606. Immunologists All rights reserved. Copyright © 2000 by The American Association of 1451 Rockville Pike, Suite 650, Rockville, MD 20852 The American Association of Immunologists, Inc., is published twice each month by
by guest on May 3, 2017 http://www.jimmunol.org/ Downloaded from by guest on May 3, 2017 http://www.jimmunol.org/ Downloaded from
Virulent Mycobacterium tuberculosis Strains Evade Apoptosis of Infected Alveolar Macrophages 1 Joseph Keane, 2 * Heinz G. Remold, † and Hardy Kornfeld* Human alveolar macrophages (AM ) undergo apoptosis following infection with Mycobacterium tuberculosis in vitro. Apoptosis of cells infected with intracellular pathogens may benefit the host by eliminating a supportive environment for bacterial growth. The present study compared AM apoptosis following infection by M. tuberculosis complex strains of differing virulence and by Mycobacterium kansasii. Avirulent or attenuated bacilli (M. tuberculosis H37Ra, Mycobacterium bovis bacillus Calmette-Gue´rin, and M. kansasii) induced significantly more AM apoptosis than virulent strains (M. tuberculosis H37Rv, Erdman, M. tuberculosis clinical isolate BMC 96.1, and M. bovis wild type). Increased apoptosis was not due to greater intracellular bacterial replication because virulent strains grew more rapidly in AM than attenuated strains despite causing less apoptosis. These findings suggest the existence of mycobacterial virulence determinants that modulate the apoptotic response of AM to intracellular infection and support the hypothesis that macrophage apoptosis contributes to innate host defense in tuberculosis. The Journal of Immunology, 2000, 164: 2016 –2020. M ycobacterium tuberculosis has evolved to survive and replicate inside macrophage phagosomes. It is postu- lated that macrophage apoptosis may contribute to host defense against this intracellular infection, analogous to apoptosis occurring in virus-infected cells. We previously reported that hu- man alveolar macrophages (AM ) 3
to intracellular M. tuberculosis infection by a TNF- ␣-dependent mechanism (1). The virulent M. tuberculosis strain H37Rv was found to induce less AM apoptosis than the isogenic avirulent strain H37Ra. We subsequently reported that IL-10 stimulation leads to shedding of soluble TNFR2 (sTNFR2) by AM and that sTNFR2 can neutralize TNF bioactivity (2). TNF- ␣ expression is critical for successful host defense of tuberculosis (3); induction of IL-10 by M. tuberculosis leading to inhibition of TNF- ␣ might constitute a novel mechanism to evade host defense by virulent bacilli The identification of M. tuberculosis virulence factors is essen- tial to understanding the pathogenesis of tuberculosis and may re- veal salient components of host defense. To date, no definitive M. tuberculosis virulence factors have been reported and few M. tu- berculosis virulence phenotypes in human cells have been de- scribed (4 – 8). We compared AM apoptosis in response to in vitro infection using a panel of mycobacterial strains of differing virulence. The results presented in this paper demonstrate that ba- cillary control of host cell apoptosis is a virulence-associated phe- notype of M. tuberculosis and suggest that AM apoptosis con- tributes to innate immunity in tuberculosis.
AM were obtained from bronchoalveolar lavage fluid of healthy non- smoking volunteers using standard techniques, with their informed consent under a protocol approved by the Institutional Review Board of the Boston University Medical Center. Lavage fluid was filtered through sterile gauze, centrifuged (450 ϫ g, 10 min), and the cell pellet was suspended in RPMI 1640 medium (Life Technologies, Gaithersburg, MD) with 10% FCS and cefotaxime 50 g/ml. Cells were plated, and nonadherent cells were re- moved by washing at 24 h. Differential counts were performed on cyto- centrifuged preparations using the Leuko Stat Stain Kit (Fisher, Pittsburgh, PA). Viability of adherent AM was assessed by trypan blue dye exclusion.
A clinical strain of M. tuberculosis was isolated from an immunocompetent patient with pulmonary tuberculosis at the Boston Medical Center (desig- nated BMC 96.1); M. tuberculosis H37Rv, H37Ra, and Erdman, as well as Mycobacterium bovis wild type, M. bovis bacillus Calmette-Gue´rin (BCG), and Mycobacterium kansasii were purchased from American Type Culture Collection (Manassas, VA). Before inoculation of AM , mycobacteria were dispersed by aspiration through a 25-gauge needle five times, vor- texed, then sonicated (15 s, 500 W) in a bath sonicator (Laboratory Sup- plies, Hicksville, NY). After sonication, bacterial suspensions were al- lowed to stand (10 min) and the upper 500 l were removed for use in experiments. For each experiment, the adequacy of dispersion and the mul- tiplicity of infection (MOI) were checked by acid-fast stain of infected AM at 4 h. Ten high-power fields were counted to provide an equivalent MOI of 5–10 bacilli per cell for each strain examined. Analysis of AM viability AM were cultured in two-well chamber slides (Nunc, Naperville, IL) at 400,000 cells per well in 1 ml of medium (37°C, 5% CO 2 ). Culture medium was replenished at 24 h, and at 72 h cells were infected with mycobacteria at an MOI of 5–10. After 4 h, cultures were washed to remove extracellular mycobacteria. After 5 days, culture supernatants were removed and AM viability was determined by staining with calcein and eithidium ho- modimer as previously described (1). One thousand cells counted by flu- orescence microscopy on each slide were scored as live (green fluores- cence) or dead (red fluorescence).
apoptosis AM in 96-well microtiter trays were infected with the different myco- bacterial strains at a MOI of 5–10. After 5 days, apoptosis was measured *Pulmonary Center, Boston University School of Medicine, Boston MA 02118; and † Department of Medicine, Brigham and Womens’ Hospital and Harvard Medical School, Boston, MA 02115 Received for publication September 21, 1999. Accepted for publication December 3, 1999. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 This work was supported in part by National Heart, Lung, and Blood Institute Grants HL-03964 and HL-44846 and by American Lung Association Grant RT-013-N. 2 Address correspondence and reprint requests to Dr. Joseph Keane, Pulmonary Cen- ter, R-3, Boston University School of Medicine, 80 East Concord Street, Boston, MA 02118. E-mail address: jkeane@lung.bumc.bu.edu 3 Abbreviations used in this paper: AM , alveolar macrophage; BCG, bacillus Calmette-Gue´rin; sTNFR2, soluble TNFR2; H37Ra, M. tuberculosis H37Ra; H37Rv, M. tuberculosis H37Rv; MOI, multiplicity of infection; T-100, time to reach a Bactec growth index of 100. Copyright © 2000 by The American Association of Immunologists 0022-1767/00/$02.00 by guest on May 3, 2017 http://www.jimmunol.org/ Downloaded from
using an Ag-capture ELISA for histone and fragmented DNA (Cell Death Detection ELISA PLUS , Boehringer Mannheim, Mannheim, Germany) on cell lysate according to the manufacturer’s protocol. Assessment of mycobacterial growth Bactec analysis of AM lysates and supernatants after bacillary infection were performed for each mycobacterial strain as previously described (9). Briefly, AM were infected with the different mycobacterial strains for 4 h or 5 days, then lysed with 0.2% SDS in PBS. SDS was neutralized by adding FCS. Cell lysate and culture supernatant from triplicate cultures were pooled and inoculated into duplicate Bactec 12B vials containing [ 14 C]palmitic acid. Vials were incubated for 24 h at 27°C, and 14 CO 2 pro-
duction was determined using a Bactec 460 TB instrument that reports a growth index in arbitrary units ranging from 0 to 999. Vials were sampled every 24 h until a reading of 999 was reached. For each experiment, the time required to reach a growth index of 100 (T-100 value) was deter- mined. Previous studies demonstrated a linear correlation between the T-100 and the log number of viable mycobacteria measured by plating and counting CFU (9). In the present study, mycobacterial growth was assessed by comparing the T-100 values 5 days after infection of AM to the initial T-100 value of the same strain 4 h after infection of AM .
␣, IL-10, and sTNFR2 release AM were incubated in the presence or absence of mycobacteria (MOI, 5–10) in triplicate cultures. Supernatants were harvested at 24 h and 5 days and passed through a 0.22- m pore-size filter (Gelman Sciences, Ann Ar- bor, MI). The level of immunoreactive TNF- ␣, IL-10, and sTNFR2 was determined using commercial ELISA kits (R&D Systems, Minneapolis, MN) in accordance with the manufacturer’s specifications.
Cytotoxicity and apoptosis data were compared by ANOVA, and myco- bacterial growth data were compared using Student’s t test. All statistical calculations were performed with InStat software (GraphPad Software, San Diego, CA).
Mycobacterial virulence is defined by the ability to cause progres- sive infection in immunocompentent humans and to cause pro- gressive infection and death in animal models (10). We infected normal human AM with mycobacteria of differing virulence at an MOI of 5–10 bound or internalized bacilli per macrophage (deter- mined by acid-fast staining of washed cells 4 h after infection). The high virulence strains investigated included M. tuberculosis BMC 96.1 (a human pulmonary tuberculosis clinical isolate with minimal passage in vitro), M. tuberculosis H37Rv, M. tuberculosis Erdman, and M. bovis wild type. Low virulence strains included in this analysis were M. tuberculosis H37Ra (an isogenic attenuated strain of H37Rv), M. bovis BCG (an isogenic avirulent strain of M. bovis), and M. kansasii. After 5 days in culture, AM viability was assessed by staining with ethidium homodimer and calcein. Con- sistent with our earlier studies that compared only H37Rv and H37Ra (1), all of the virulent mycobacterial strains caused signif- icantly less AM cytotoxicity than the attenuated strains (Fig. 1A). As an example, BCG induced 43% Ϯ 7% cell death (mean % dead cells
Ϯ SEM for eight experiments; p Ͻ 0.001), while infection with M. bovis wild type was associated with no additional AM death over uninfected control levels of 3 Ϯ 1%. AM apoptosis is more potently induced by attenuated than virulent mycobacteria To investigate relative induction of AM apoptosis by virulent and attenuated mycobacteria, cultures of infected cells were assayed using an apoptosis-specific ELISA for cytoplasmic histone-asso- ciated DNA fragments formed in apoptotic cells. Infection with virulent M. tuberculosis complex strains consistently resulted in less AM
apoptosis than infection with attenuated strains (Fig. 1B). Virulent M. tuberculosis BMC 96.1 and H37Rv, as well as with M. bovis wild type, failed to increase AM apoptosis above the baseline value for uninfected cells. In contrast, the attenuated strains H37Ra, BCG, and M. kansasii all caused a significant in- crease in AM apoptosis over control. FIGURE 1. Virulent M. tuberculosis complex strains cause less AM cell death and apoptosis than isogenic avirulent strains or the attenuated strain
were cultured on microscopy chamber slides and infected with each of seven different mycobacterial strains. Uninfected AM were used as controls. After staining with ethidium homodimer and calcein, slides were examined by epifluorescence microscopy and 1000 cells were scored as live or dead. Viability is expressed as mean % dead cells Ϯ SEM for seven experiments. Significant differences (p Ͻ 0.05) are indicated by an asterisk.
as measured by histone/fragmented DNA ELISA. AM cultured in microtiter plates were infected with each of seven different strains of mycobacteria. Uninfected AM cultured in an identical manner served as controls. After 5 days, the histone and fragmented DNA content of the cells was assessed by Ag-capture ELISA. Relative apoptosis in these cultures is expressed as the mean OD Ϯ SEM for three separate experiments. Significant differences compared with control (p Ͻ 0.05) are indicated by an asterisk. 2017 The Journal of Immunology by guest on May 3, 2017 http://www.jimmunol.org/ Downloaded from
AM apoptosis is not due to rapid intracellular mycobacterial growth Previous experiments have reported faster intracellular growth rates by virulent mycobacteria in human monocytes and mono- cyte-derived macrophages (7, 8, 11). Increased AM cytotoxicity and apoptosis after infection by attenuated mycobacterial strains might reflect more rapid growth and accumulation of intracellular bacilli that could impair critical host cell functions. To investigate this possibility, growth in AM was assessed by Bactec analysis for each of the seven mycobacterial strains employed in these stud- ies (Fig. 2). The mycobacterial content in AM cultures at 4 h (day 0) was compared with that at day 5 for each strain. A T-100 value (time for the inoculated Bactec vial to reach a growth index of 100) was determined for each strain and time point. The percent change in T-100 over time was calculated using the equation, % ⌬T-100 ϭ
(T-100 day 5/T-100 day 0) ϫ 100. The virulent mycobacterial stains that caused the least amount of cytotoxicity and apoptosis demonstrated considerable growth in the AM over 5 days. In contrast, the attenuated bacilli declined in numbers over the same time period. This indicates that increased intracellular bacillary burden is not responsible for the observed high AM apoptosis rates with these strains and suggests that host macrophage apopto- sis might contribute to mycobacterial growth restriction.
␣ or to shedding of sTNFR2 M. tuberculosis-infected AM become primed for TNF-␣-medi- ated cytotoxicity, and infection-induced apoptosis appears to be primarily due to autocrine or paracrine TNF- ␣ death signals (1). We previously found that IL-10 down-regulates AM apoptosis after M. tuberculosis infection by releasing sTNFR2 that neutral- izes TNF- ␣ (2). Differences in AM apoptosis following infection by different mycobacterial strains could reflect differences in the production of TNF- ␣ or IL-10 and/or differences in the shedding of sTNFR2 from infected cells. This question was assessed in the present study by measuring TNF- ␣, IL-10, and sTNFR2 in super- natants of AM 24 h and 5 days after infection with each of the seven mycobacterial strains studied. There were large variations in the response of AM from different donors, with no consistent relationship between the level of TNF- ␣, IL-10, or sTNFR2 and the virulence of infecting organism (Fig. 3). Similarly, no consis- tent relationship between cytokine or sTNFR2 levels were found in the same donor cells when infected with virulent or attenuated bacilli. The levels of TNF- ␣, IL-10, and sTNFR2 at day 5 were moderately increased compared with 24 h while the overall pattern of cytokine expression was similar at both time points (data not shown). These data do not exclude a role for IL-10 or sTNFR2 in regulating apoptosis of M. tuberculosis-infected AM , but they suggest the presence of additional mechanisms acting to modulate this response.
We found a consistent pattern of reduced AM apoptosis and cy- totoxicity after infection by virulent M. tuberculosis complex ba- cilli as compared with attenuated or avirulent isogenic strains and
intracellular growth than the attenuated strains despite their asso- ciation with enhanced host macrophage viability. We were unable to establish a consistent relationship between the levels of TNF- ␣, IL-10, or sTNFR2 and the relative virulence of the infecting or- ganism or the fate of the infected cells. While differential induction of these factors may play a role in specific cases, it appears that other mechanisms may also be involved in the modulation of AM apoptosis by virulent M. tuberculosis. AM are the primary host cell for inhaled M. tuberculosis, which has adapted to survive and replicate within the phagosome. Apoptosis can be an effective defense strategy to limit the growth of intracellular pathogens (12). The importance of this innate de- fense mechanism is demonstrated by the evolutionary acquisition of apoptosis-inhibiting genes by many viruses. Our data suggest that macrophage apoptosis also plays a role in defense against M. tuberculosis. In vitro infection with M. tuberculosis induces AM apoptosis in a TNF- ␣-dependant manner (1), and apoptotic mac- rophages are present in pulmonary granulomas and in bronchoal- veolar lavage cells from patients with tuberculosis (13, 14). There are several mechanisms whereby macrophage apoptosis might act to limit M. tuberculosis replication in the lung. Other investigators have found that the induction of infected monocyte/ macrophage apoptosis by exogenous factors, but not the induction of infected cell necrosis, limits mycobacterial growth in vitro and retains bacilli in apoptotic bodies (15, 16). In addition to depriving bacilli of an intracellular environment that facilitates growth, there is evidence that ingestion of bacilli contained in apoptotic cells by freshly added macrophages results in an augmented microbicidal effect (9). Our data presented here indicates that evasion of host AM apoptosis is a M. tuberculosis virulence-associated pheno- type. This supports the hypothesis that apoptosis contributes to innate immunity in tuberculosis. This is the first study to show phenotypic differences among different strains of M. tuberculosis in an in vitro assay using human AM . By studying the behavior of human AM following M. tuberculosis infection, and by employing clinical mycobacterial isolates, phenotypes more germane to human tuberculosis may be FIGURE 2. Growth or inhibition of different mycobacterial strains after infection of human AM . Mycobacterial growth was measured using a Bactec 14
2 sampler. The time to reach a Bactec growth index of 100 (T-100) decreases with increasing numbers of bacilli in any sample and is linearly correlated with log CFU determined by plating and colony count- ing (9). In the current study, the T-100 on day 0 reflects the number of intracellular bacilli initially introduced into the cultured AM , while the T-100 measured at day 5 reflects the number of intracellular bacilli 5 days later. The % change in T-100 over 5 days was calculated using the equa- tion, %
⌬T-100 ϭ (T-100 day 5/T-100 day 0) ϫ 100. A positive value represents intracellular bacterial growth over this time period, while a neg- ative value represents a bactericidal effect. One representative of three different experiments is shown. The difference in growth rates between attenuated mycobacterial strains and virulent strains was significant (p Ͻ 0.05) using an unpaired t test. A qualitatively similar result was observed in three different experiments using AM from different donors. 2018 MACROPHAGE APOPTOSIS AND M. tuberculosis VIRULENCE by guest on May 3, 2017 http://www.jimmunol.org/ Downloaded from
described. Mycobacterial growth rates in a variety of human cells have been investigated, and it has been reported that virulent strains replicate faster than avirulent strains (4 – 8, 11). The basis for this phenomenon has not been established, but our findings suggest that differential induction of infected macrophage apopto- sis may be an important factor. Attenuated bacilli caused more AM cytotoxicity than virulent strains in our experiments, yet the growth of the attenuated strains was restricted. This is consistent with previous reports that the use of exogenous agents such as H 2
2 to cause apoptosis of mycobacteria-infected macrophages results in mycobacterial death (15). Our studies are unique in that apoptosis occurred as a direct result of mycobacterial infection, better reflecting events occurring naturally in tuberculosis. The ca- pacity of virulent mycobacteria to modulate AM apoptosis can reasonably be related to the preservation of a supportive intracel- lular environment for bacterial growth. By inhibiting host macro- phage apoptosis, the mycobacteria also avoid being packaged in apoptotic bodies that are subject to secondary phagocytosis by newly recruited mononuclear cells. It is postulated that uptake of bacilli packaged in this way leads to more effective intracellular microbicidal processing (9). TNF- ␣ and IL-10 have central roles in the innate response to M. tuberculosis infection (3, 17), and we described the influence of these cytokines on AM apoptosis after M. tuberculosis infection (2). We found that TNF- ␣ and IL-10 responses of primary human AM to M. tuberculosis infection do not correlate with microbial virulence, suggesting that additional mechanisms also are involved in the modulation of infected AM apoptosis. The identification of contrasting apoptosis-induction phenotypes by the isogenic pairs H37Ra and H37Rv, as well as BCG and M. bovis wild type, may offer a means for identifying the microbial genetic basis for this difference. Analysis of apoptosis responses by murine macrophage cell lines suggests that host genetic factors may also contribute to the regulation of cell fate in tuberculosis (18). While we observed significant variability in cytokine production by AM from dif- ferent human donors, the pattern of apoptosis responses has been very consistent in our experience.
We are grateful to Drs. Jussi Saukkonen, Michael Ieong, and Christine Reardon for assistance in bronchoscopy and to Beth Shurtleff for technical assistance. References 1. Keane, J., M. K. Balcewicz-Sablinska, H. G. Remold, G. L. Chupp, B. B. Meek, M. J. Fenton, and H. Kornfeld. 1997. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65:298. 2. Balcewicz-Sablinska, M., J. Keane, H. Kornfeld, and H. Remold. 1998. Patho- genic Mycobacterium tuberculosis evades apoptosis of host macrophages by re- lease of TNF-R2, resulting in inactivation of TNF- ␣. J. Immunol. 161:2636. 3. Flynn J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak and B. R. Bloom. 1995. Tumor necrosis factor- ␣ is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561. 4. Shepard, C. C. 1958. A comparison of the growth of selected mycobacteria in HeLa, monkey kidney, and human cells in tissue culture. J. Exp. Med. 107:237. 5. Byrd, T. F., G. M. Green, S. E. Foxlston, and C. R. Lyons. 1998. Differential growth characteristics and Streptomycin suceptability of virulent and avirulent
colony assay. Infect. Immun. 66:5132. 6. McDonough, K., and Y. Kress. 1995. Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect. Immun. 63:4802. 7. Silver, R., Q. Li, and J. Ellner. 1998. Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor ␣ but not with evasion of lym- phocyte-dependent monocyte effector functions. Infect. Immun. 66:1190. 8. Zhang, M., J. Gong, Y. Lin, and P. Barnes. 1998. Growth of virulent and avirulent
Induction of TNF- ␣, IL-10, and sTNFR2 following in vitro infection of human AM with different M. tuberculosis complex strains and M. kansasii. Supernatant from cultures of infected cells was harvested at 24 h. Identical cultures of uninfected cells served as controls. Commer- cial ELISA kits were used to measure TNF- ␣ (A), sTNFR2 (B), and IL-10 (C). Each symbol represents the values derived from a different AM donor. Qualitatively similar results were observed in cultures of AM in- fected for 5 days (data not shown). 2019 The Journal of Immunology by guest on May 3, 2017 http://www.jimmunol.org/ Downloaded from
9. Fratazzi, C., R. D. Arbeit, C. Carini, and H. G. Remold. 1997. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol. 158:4320. 10. Dunn, P. L., and R. J. North. 1995. Virulence ranking of some Mycobacterium
tiply in the lungs, induce lung pathology, and cause mortality in mice. Infect. Immun. 63:3428. 11. Mackaness, G. B., N. Smith, and A. Q. Wells. 1954. The growth of intracellular tubercle bacilli in relation to their virulence. Am. Rev. Tuberculosis. 69:479. 12. Vaux, D. L., and A. Strasser. 1996. The molecular biology of apoptosis. Science 93:2239. 13. Placido, R., G. Mancino, A. Amendola, F. Mariani, S. Vendetti, M. Piacentini, A. Sanduzzi, M. L. Bocchino, M. Zembala, and V. Colizzi. 1997. Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection. J. Pathol. 181:31. 14. Klingler, K., K.-M. Tchou-Wong, O. Brandli, C. Aston, R. Kim, and W. N. Rom. 1997. Effects of mycobacteria on regulation of apoptosis in mononuclear phago- cytes. Infect. Immun. 65:5272. 15. Molloy, A., P. Laochumroonvorapong, and G. Kaplan. 1994. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Gue´rin. J. Exp. Med. 180:1499. 16. Oddo, M., T. Renno, A. Attinger, T. Bakker, H. MacDonald, and P. Meylan. 1998. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol. 160:5448. 17. Zhang, M., J. Gong, D. V. Iyer, B. E. Jones, R. L. Modlin, and P. F. Barnes. 1994. T cell cytokine responses in persons with tuberculosis and human immunodefi- ciency virus infection. J. Clin. Invest. 94:2435. 18. Rojas, M., L. F. Barrera, G. Puzo, and L. F. Garcia. 1997. Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages. J. Immunol. 159:1352. 2020 MACROPHAGE APOPTOSIS AND M. tuberculosis VIRULENCE by guest on May 3, 2017 http://www.jimmunol.org/ Downloaded from Yüklə 101,21 Kb. Dostları ilə paylaş:
|